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Summary
BACKGROUND: Continuous deep sedation until death is
increasingly used to treat intolerable suffering of terminal-
ly ill patients. One of the highest incidences and strongest
increases has been observed in Switzerland. Variation in
prevalence estimates indicates a potential effect of differ-
ences in sedation practice between care settings and pro-
fessionals.
AIM: To explore physicians’ and nurses’ conceptual under-
standing of continuous deep sedation and unravel deci-
sion-making processes in everyday clinical practice.
METHODS: Between June and October 2016, we con-
ducted seven qualitative focus groups with 47 healthcare
professionals (21 physicians and 26 nurses) involved in
sedation decision and administration.
RESULTS: Participants had on average 20 years (range
3–39) of clinical experience, 10 years (range 0–30) of self-
reported palliative care experience, and a mean annual
number of 5 patients (range 1–20) continuously deeply se-
dated until death. Continuous deep sedation until death
covers a wide spectrum of practices: specialised palliative
sedation induced through benzodiazepines to treat refrac-
tory symptoms as option of last resort, sedation as comfort
therapy with benzodiazepines or opioids, and sedation
taken into account as a side effect of gradually increased
analgesia.
CONCLUSION: We found substantial variation in termi-
nology and definition, indication and medication used for
continuous deep sedation until death. To provide optimal
symptom management in terminally ill patients, early in-
volvement of palliative care experts as well as financial
and regulatory support should be provided to encourage
multi-disciplinary collaboration and thus consensus for
defining the distinct sedation practices.
Keywords: deep sedation, palliative care, multidiscipli-
nary communication, qualitative research
Introduction
In end-of-life care, alleviation of patients’ unbearable suf-
fering is everyday clinical practice. Where conventional
symptom control is not sufficient, “palliative sedation” can
be considered. According to a patient’s need, palliative se-
dation is mild or deep and induced intermittently or con-
tinuously until death [1]. Population-wide studies have es-
timated the overall prevalence of such continuous deep
sedation until death to vary between 2.5 and 18.3% [2–8],
with one of the highest incidences and strongest increases
observed in Switzerland from 4.7% in 2001 to 17.5% in
2013 [7, 9].
Since 1963 terminology has become increasingly complex,
leading to a diversity of terms used [10]. To standardise
the procedure for this sedation, several practice guidelines
have been developed [11]. According to the European As-
sociation of Palliative Care (EAPC), palliative sedation is
only indicated when the professionals’ intention is to re-
lieve patients’ refractory suffering as option of last resort,
not any attempt to hasten death [12]. Benzodiazepines are
the medication of first choice and the use of opioids is con-
sidered inappropriate [13].
Palliative sedation guidelines have predominantly been de-
veloped in the context of specialised palliative care, where-
as two thirds of all deaths in Switzerland occur in acute
care hospitals and long-term care facilities [14, 15]. Devi-
ations from clinical guidelines seem likely and are caused
by on-going ethical discussions around the belief that con-
tinuous deep sedation until death is life-shortening [16].
This seems particularly the case for less experienced pro-
fessionals working in non-specialised settings [17]. Today,
there is little evidence clarifying whether in everyday clin-
ical practice, both within and outside of specialised pal-
liative care, continuous deep sedation is performed ac-
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cording to the concept and implementation presented in
the aforementioned guidelines. Therefore, we aimed to ex-
plore physicians’ and nurses’ understanding of continuous
deep sedation and to unravel decision-making processes in
everyday clinical practice.
Methods
We reported this study according to the Consolidated Cri-
teria for Reporting Qualitative Research (COREQ) guide-
lines [18]. To elicit healthcare professionals’ experience
and perspective on continuous deep sedation until death
and to foster conversations within different domains be-
tween healthcare professionals, we conducted qualitative
focus groups in German-speaking Switzerland between
June and October 2016. The study was approved by the
Zurich Cantonal Ethics Board (KEK-StV-Nr. 23/13).
Participant selection and setting
To cover the whole spectrum of healthcare professionals
potentially confronted with the administration of continu-
ous deep sedation until death, we focused on: (i) general
and specialised palliative care settings defined in the Swiss
framework of palliative care and (ii) care divisions that
treat patients suffering from palliative care-relevant dis-
eases based on the International Classification of Dis-
eases-10 codes used to estimate palliative care need. We
recruited physicians and nurses from hospitals, nurses
from nursing homes, and family practitioners (fig. 1).
In total, we identified 13 hospitals via the hospital register
of the Swiss Federal Office of Public Health and included
all hospitals in German-speaking Switzerland of level 1 (3
university hospitals) and level 2 (10 general hospitals, cen-
tralised support). According to palliative care relevant dis-
eases, we sampled within the departments of internal med-
icine, pulmonology, cardiology, neurology, oncology and
intensive care units (ICUs) (18 departments in 3 universi-
ty hospitals, 58 departments in 10 cantonal general hospi-
tals). To complete our coverage of general palliative care
settings, we furthermore contacted 994 nursing homes via
the Swiss association of social homes and institutions (Cu-
raviva) and 3780 family practitioners via the Swiss associ-
ation of general practitioners (mfe) as well as 12 prespeci-
fied family practitioners.
We approached eligible participants from hospitals and
nursing homes by e-mailing the study invitation and infor-
mation to the senior clinical staff and asking them to nom-
inate physicians and nurses actually involved in sedation
decision and administration. Invitations for family practi-
tioners were sent to 12 preselected physicians personally
and to 3780 anonymously as part of an online newsletter of
the mfe.
Participants were eligible if they had been closely involved
in the care or decision-making process for patients contin-
uously deeply sedated until death in the last 3 years.
Data collection
Focus groups with participants from hospitals were
grouped into the core care team of continuously deeply
sedated patients and if available their significant interdis-
ciplinary collaborators. The five multi-professional focus
groups were held at the respective hospitals. The two focus
groups with nurses from long-term care institutions were
Figure 1: Recruitment process of focus group participants.CDS = continuous deep sedation until death
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held either in Zurich or in Olten. Each nurse represented a
different long-term care institution.
All discussions were led by an independent and experi-
enced moderator and lasted on average 90 minutes. We au-
diotaped each focus group and transcribed them verbatim.
Two observers (SZ and MS) made notes to record the order
of the individual quotes and to maintain contextual details
and non-verbal expressions for data interpretation.
Discussion guide
The moderator followed a predefined discussion guide
which was pilot tested through 10 expert interviews. Pre-
vious findings of the fourfold increase of continuous deep
sedation until death in German-speaking Switzerland be-
tween 2001 and 2013 were used to initiate the discussion
[7]. The discussion guide consisted of open questions and
prompts covering six topics derived from the EAPC frame-
work: (i) terminology and definition; (ii) indication; (iii)
decision-making process; (iv) administration and monitor-
ing; (v) evaluation; (vi) moral concerns. To obtain termi-
nology related differences in sedation understanding across
healthcare professionals, participants were asked about the
term used to describe “the administration of drugs, such as
benzodiazepines and/or other sedative substances, to keep
a patient in deep sedation or coma until death” [7]. From
all participants, we additionally obtained information on
demographics (table 1) and experience with continuous
deep sedation (table 2).
Data analysis
Two coders (SZ, MS) independently analysed the tran-
scripts according to Mayring’s qualitative content analysis
using the MAXQDA software (MAXQDA Analytics Pro,
version 12, 1995–2017, VERBI GmbH, Berlin, Germany).
In a first step, we assigned all statements to pre-identified
themes related to the six categories covered in the discus-
sion guide. Based on these initial themes we inductively
derived major differences between healthcare profession-
als’ palliative specialisation and care settings. Therefore,
physicians and nurses were identified as palliative care
specialists when they had postgraduate palliative care
training such as a Master of Advanced Studies or postgrad-
uate training. Disagreements were minimal and resolved
through discussion.
Results
We organised seven focus groups with 47 healthcare pro-
fessionals (21 physicians, 26 nurses) from long-term care
and hospitals (palliative care unit (PCU), ICU, general
internal medicine, and oncology) in German-speaking
Switzerland. Participants had on average 20 years (range
3–39) of clinical experience, 10 years (range 0–30) of self-
reported palliative care experience, and a mean annual
number of 5 (range 1–20) patients continuously deeply se-
dated until death with the last sedation 5 days to 3 years
ago (table 2).
Terminology
Focus group participants used heterogeneous terminology
to describe continuous deep sedation until death. Most
physicians and nurses referred to the term “palliative se-
dation” or “terminal sedation”, but outside specialised pal-
liative care several healthcare professionals used a broader
terminology such as “symptom control”, “supportive
care”, “comfort therapy” or no specific term at all (table 3).
In some institutions, professionals described issues with
the term “terminal sedation” as the word “terminal” might
Table 1: Healthcare professionals’ sociodemographics and clinical work experience. Figures are percent and (numbers) unless otherwise stated.
Characteristics Total
(n = 47)
Hospital*
(n = 36)
Long-term care*
(n = 11)
Age in years; mean (SD) 47.8 (8.9) 46.3 (9.0) 52.5 (6.5)
Sex
Female 63.8 (30) 71.0 (21) 30.0 (9)
Male 36.2 (17) 88.2 (15) 11.8 (2)
Profession
Physician 44.7 (21) 100 (21) -
Nurse 55.3 (26) 57.7 (15) 42.3 (11)
Healthcare setting†
Nursing home / hospice 23.4 (11) 0.0 (0) 100 (11)
Palliative care unit 27.7 (13) 36.1 (13) -
Mobile palliative care 2.1 (1) 2.8 (1) -
Conciliar palliative care 4.3 (2) 5.6 (2) -
General internal medicine 8.6 (4) 11.1 (4) -
Oncology 23.4 (11) 30.6 (11) -
Intensive care unit 6.4 (3) 100 (3) -
Emergency department 4.3 (2) 5.6 (2) -
Clinical experience in years; mean years(SD)‡ 20.4 (9.2) 18.3 (8.6) 27.0 (7.7)
Palliative care experience in years; mean years(SD)‡ 9.8 (7.3) 9.3 (7.2) 11.3 (7.6)
Palliative care specialisation
Specialised palliative care§ 55.3 (26) 80.8 (21) 19.2 (5)
Other 44.7 (21) 71.4 (15) 28.6 (6)
SD = standard deviation. * Figures are row percent if not otherwise stated. Missing data were omitted for percentages. † For healthcare settings figures are column percent. ‡
Missing data: 1 for clinical experience, 2 for palliative care experience. § Specialised palliative care includes all healthcare professionals with postgraduate palliative care training
such as a Master of Advanced Studies, postgraduate training level B2.
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indicate an action to terminate someone’s life rather than
the disease stage.
“I associate the term ‘terminal sedation’ with something
very active, meaning that I intentionally hasten the pa-
tient’s death.” (Physician 1, FG5, Hospital)
Physicians and nurses within the same care team used a
common terminology, including a shared understanding of
the sedation practice. But across institutions, care settings
and hospital departments, professionals described difficul-
ty in finding a unique term sufficient for a common under-
standing.
“I think terminology is used differently between clinical
settings and hospital departments such as acute hospital,
surgery, or gynaecology. Sometimes terms are not used
carefully but if you ask explicitly, it gets obvious what they
really mean.” (Nurse 1, FG7, Hospital)
Indications to sedate a patient continuously until death
All healthcare professionals agreed that the primary inten-
tion of continuous deep sedation until death was to treat
a patient’s unbearable suffering. Palliative care special-
ists consistently described continuous deep sedation un-
til death as an explicitly intended treatment. Outside spe-
Table 2: Healthcare professionals’ clinical experience with continuous deep sedation until death. Figures are column percent and (numbers) unless otherwise stated.
Characteristics Non-specialised palliative care
(n = 21)
Specialised palliative care*
(n = 26)
Annual number of patients continuously deeply sedated, mean† 5.6 5.3
Last sedated patient in months, mean months(SD)† 8.0 (10.2) 7.0 (8.4)
Terminology†‡
Palliative sedation 53.8 (7) 42.9 (9)
Terminal sedation 15.4 (2) 57.1 (12)
Continuous deep sedation 15.4 (2) 9.5 (2)
Symptom control / supportive care / comfort therapy 23.1 (3) 4.8 (1)
None 23.1 (3) -
Indication†‡
Dyspnoea 58.8 (10) 56.6 (13)
Delirium 23.5 (4) 53.9 (14)
Pain 70.6 (12) 50.0 (13)
Anxiety 41.2 (7) 23.1 (6)
Massive haemorrhage - 11.5 (3)
Patient’s wish 17.7 (3) 7.7 (2)
Other symptoms 22.2 (4) 11.5 (3)
Medication†
Benzodiazepines alone 25.0 (4) 87.5 (21)
Opioids alone 25.0 (4) -
Benzodiazepines + opioids 43.8 (7) 12.5 (3)
Other 6.3 (1) -
Guidelines†‡
Bigorio 11.1 (2) 65.4 (17)
Internal 50.0 (9) 53.9 (14)
EAPC 11.1 (2) 26.9 (7)
Others 22.2 (4) 26.9 (7)
None 33.3 (6) -
SD = standard deviation; EAPC=European Association of Palliative Care * Includes all healthcare professionals with postgraduate palliative care training such as a Master of
Advanced Studies, postgraduate training level B2. † Missing data: 8 for annual number of sedated patients, 6 for last sedated patient, 4 for indication, 7 for medication, 3 for
guidelines, 13 for terminology. Missing data were omitted for percentages. ‡ Multiple answer question – percentages may add up to more than 100.
Table 3: Healthcare professionals' practices of administering sedatives to keep a patient in deep sedation until death.
Palliative care specialists
(n = 26)
Professionals without palliative care specialisation
(n = 21)
Term used Palliative sedation
Terminal sedation
Continuous deep sedation
Palliative sedation Terminal sedation
Comfort therapy Supportive care
Symptom control
No terminology at all
Comfort therapy
Supportive care
Symptom control
No terminology at all
Indication Patient’s unbearable suffering, given symptoms are
refractory
Patient’s unbearable suffering Patient’s unbearable suffering
Intention Relieving patients suffering by reducing patient’s
consciousness
Relieving patients suffering by reducing
patient’s consciousness
Intensified alleviation of symptoms taking in-
to account sedation as side-effect
Decision-making process Multi- and interdisciplinary teamwork including pa-
tient and family
Multi- and interdisciplinary teamwork in-
cluding patient and family
Multi- and interdisciplinary teamwork includ-
ing patient and family
Timing Discussions early in disease trajectory ACP Discussions early in disease trajectory
ACP
Not specifically timed
Administration Dose titration, SC–IV
24-hour monitoring necessary
Dose titration, SC–IV Dose titration, SC–IV
Sedative agents Benzodiazepines Opioids alone or with benzodiazepines Opioids alone or with benzodiazepines
ACP = Advance Care Planning; SC = subcutaneous; IV = intravenous. * Specialised palliative care includes all participants with postgraduate palliative care training.
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cialised palliative care, deep sedation was also reported as
a side-effect of intensified alleviation of pain.
“Quite often we see [in different hospital departments],
that sedation is the effect of intensified symptom control,
but not a treatment goal which was explicitly planned in
advance.” (Consulting Physician 2, FG7, Palliative Care)
There were further differences regarding the patient’s level
of suffering and the restriction to refractory symptoms.
Palliative care professionals consistently emphasised the
use of continuous deep sedation as an option of last resort
and only in case of refractory symptoms.
“It is crucial to differentiate between refractory symptoms
and inadequate symptom control.” (Physician 3, FG3, Pal-
liative Care)
Outside specialised palliative care, physicians and nurses
also agreed on patients’ unbearable suffering but did not
consistently limit sedation to refractory symptoms. Partic-
ularly in long-term care, where residents die in very old
age, continuous deep sedation was more often described
for serious pain, anxiety and existential suffering.
“We have two types of residents eligible for sedation. First,
residents who simply do not want to experience the dying
process. These residents often wish to be put asleep in or-
der to not perceive death consciously. Second, residents
suffering of severe pain who expressed the wish for a seda-
tion.” (Nurse 2, FG2, Long-term care)
Continuous deep sedation in the event of psychological
symptoms was discussed as a rare and demanding excep-
tion that requires special expertise and discussion. In gen-
eral, healthcare professionals reported difficulty in sepa-
rating psychological from physical suffering, because the
complexity of a patient’s clinical situation includes both
emotional and physical burden.
“In the case of existential suffering, the decision to start
sedation is of course difficult. Even if the psychological
symptoms are comprehensible, it is easier for us to make
a decision in case of massive dyspnoea. Of course, we
have to take psychological symptoms seriously but deci-
sion-making is much more difficult.” (Nurse 3, FG3, Pal-
liative Care)
Deciding about continuous deep sedation until death
Palliative care professionals highlight the importance to
discuss the decision with a competent patient early in the
disease trajectory in order to inform the patient and get his
consent.
“We always get patients’ informed consent in advance. If
a patient is not capable of decision-making, sedation with
benzodiazepines is not considered as a treatment option.”
(Palliative Care Nurse 4, FG2, Long-term care)
Where sedation is not an explicitly intended treatment, but
rather a gradual process during increased disease progres-
sion, discussions with competent patients are not always
possible anymore.
“I think we do not have the characteristic patient popula-
tion which is eligible for terminal sedation at a specific
time. In our tumour patients, this is a gradual develop-
ment…patients usually are already comatose and not capa-
ble anymore to decide whether they really want that or not.
In most cases the family members are the ones who have
to make the decisions.” (Physician 1, FG5, Hospital)
All healthcare professionals emphasised the importance of
multi- and interdisciplinary team sessions. Depending on
the care setting, there are different opportunities to call in
other professions. In hospitals, particularly university hos-
pitals, healthcare professionals have wide access to other
specialties.
In contrast, nursing homes’ multi- and interdisciplinary
collaboration is often limited to internal in-patient physi-
cians, external family practitioners and non-medical pro-
fessions. Where nurses have to deal with several different
family practitioners, they often reported difficulties owing
to various treatment approaches and palliative care atti-
tudes.
“We have four to five physicians responsible for our resi-
dents, each with a different treatment approach. With some
physicians, we have to fight for adequate palliation, where-
as for others palliative care is taken for granted.” (Nurse 5,
FG1, Long-term care)
Independent of the care setting and palliative care special-
isation, all physicians and nurses highlighted the impor-
tance of involving family members and relatives. As proxy,
family members and relatives not only play a role in the de-
cision-making process, they are also part of the unit of care
with their own suffering. Some healthcare professionals re-
ported feeling pressured from relatives to start sedation.
But all agreed that continuous deep sedation until death is
not indicated just because of relatives’ request.
“Palliative sedation is not indicated upon relatives’ re-
quest. However, this gives reason to the need for further
talks. Because palliative sedation requires consent between
patient, relatives, and healthcare professionals, different
treatment preferences and goals have to be discussed at a
‘round table’. In my opinion this is a matter of time and
communication.” (Physician 4, FG6, Palliative Care)
Administration, monitoring and evaluation
In line with international guidelines, all palliative care spe-
cialists agreed on using benzodiazepines – subcutaneous or
intravenous – as medication of first choice to intentional-
ly induce deep sedation. They clearly separate the use of
analgesics for symptom control from sedation and there-
fore, opioids were described as inappropriate.
“We never use opioids as sedative agents. Of course, if
necessary, analgesic treatment continues during sedation.
Opioids only have sedative effect when overdosed. There-
fore, sedation through increased dose titration of opioids
is considered inappropriate.” (Physician 5, FG3, Palliative
Care)
Other than in emergency situations, continuous deep seda-
tion until death was usually preceded by intermittent seda-
tion with gradual dose titration to a minimum level nec-
essary for palliation. Therefore, re-evaluation and 24-hour
monitoring of symptom distress and relief should be pro-
vided.
“We constantly monitor the patient and re-evaluate the sit-
uation if needed every two hours to check whether he is
breathing relaxed and how he reacts when changing his po-
sition.” (Palliative Care Nurse 4, FG 2, Long-term care)
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Outside specialised palliative care, healthcare profession-
als described the use of both benzodiazepines and opioid
analgesics – subcutaneous or intravenous – to explicitly in-
duce continuous deep sedation until death by gradual dose
titration to a minimum level necessary for palliation.
“In our institution, patients are continuously deeply sedat-
ed until death through morphine, not benzodiazepines.”
(Nurse 6, FG2, Long-term care)
In contrast to palliative care specialists, re-evaluation and
24-hour monitoring was less emphasised by healthcare
workers outside specialised palliative care.
“In the terminal stage, it makes no sense to constantly
monitor a patient’s blood pressure, heart rate or everything
else. Of course, we regularly visit the patient but we also
try to get away from too many technical instruments to
make the situation more bearable for the family.” (Physi-
cian 6, FG5, Hospital)
Furthermore, sedation was described as a gradual process
during intensified alleviation of symptoms. In this case, se-
dation was not explicitly intended but taken into account as
side-effect of increased opioid analgesics. Thus, constant
monitoring and re-evaluation of the sedation itself was not
considered.
“Terminal sedation has not actually been named so far. Se-
dation is rather part of a gradual process, first we admin-
ister morphine, than Haldol and finally Dormicum. We do
not plan to start sedation at a specific time e.g., today at
4pm. The use of the term ‘terminal sedation’ just recent-
ly developed among palliative care physicians. There are
clinical practice guidelines available for everyone on pal-
liative.ch, but in everyday clinical practice it is different.”
(Physician 1, FG5, Hospital)
Moral concerns
Where continuous deep sedation was well discussed and
documented, and consensus was reached between the pa-
tient, the family and the healthcare team, moral concerns
where not present. In one team, there were moral concerns
when administering continuous deep sedation until death
for the first time.
“The first time we sedated a patient continuously deeply
until death, my team was very concerned about having has-
tened the patient’s death. We afterwards re-evaluated the
situation to differentiate between continuous deep seda-
tion until death and physician assisted death. In contrast
to physician assisted death, we do not administer benzodi-
azepines with the intention to hasten death nor do benzo-
diazepines hasten death either. It’s very important to take
moral concerns seriously and discuss them adequately.”
(Palliative Care Nurse 7, FG1, Long-term Care)
The more healthcare professionals struggled with justi-
fying the sedation practice, the higher the risk of expe-
riencing moral concerns. Our findings revealed that this
appeared to be in part a function of lack of proper decision-
making to reach a consensus within the team, as well as
with patients and family (e.g., lack of time in emergency
case).
“We always try to document and discuss palliative sedation
sufficiently in order to reach a consensus with the patient,
the family and within the healthcare team. But in emer-
gency situations you have to act immediately. Retrospec-
tively you might see things more clearly and maybe you
would have done things differently.” (Consulting Physi-
cian 2, FG7, Palliative Care)
Discussion
Our study reveals that healthcare professionals with and
without palliative care specialisation have a different un-
derstanding of “continuous deep sedation until death”. Pal-
liative care specialists defined continuous deep sedation
until death most restrictively as the explicitly intended use
of benzodiazepines in order to treat refractory symptoms
as an option of last resort. Outside specialised palliative
care, healthcare professionals put less emphasis on refrac-
tory symptoms and not only described sedation as an ex-
plicitly intended treatment but also as a side-effect taken
into account with intensified alleviation of symptoms.
In line with previous studies we found a lack of consistent
terminology and definitions [19]. While palliative care
specialists consistently used “palliative”, “terminal”, or
“continuous deep sedation”, outside specialised palliative
care, sedation was sometimes described more generally as
“symptom control” or “comfort therapy”. Papavasiliou and
colleagues revealed that the heterogeneity in definitions
seems to be caused by differences in language and vo-
cabulary used by healthcare professionals of different care
settings [20]. But even when a common term was used,
healthcare professionals did not necessarily describe the
same understanding of the sedation practice. The fact that
nurses felt they had to push physicians for appropriate pal-
liation, might be the result of a breakdown in communica-
tion where the same term, and what constitutes appropriate
sedation practices, mean different things to different pro-
fessions. Thus, in certain settings patients might be at risk
of getting insufficient relief from their suffering. There-
fore, it seems that a universally agreed term is not suffi-
cient for a common understanding.
Beside the heterogeneous terminology, our results high-
light the problematic field of indication. For palliative care
specialists, continuous deep sedation is only indicated
when a symptom is refractory. But, whether a symptom is
regarded as refractory differs according to healthcare pro-
fessionals’ clinical experience and available resources. Re-
gardless of professionals’ palliative care specialisation, all
healthcare professionals emphasise that a patient’s unbear-
able suffering indicates a need for palliative sedation. In
clinical practice, it can be unclear what “unbearable suffer-
ing” entails and to what extent physical and psychological
suffering is relevant. According to Bozzaro and colleagues,
the problem originates in the definition of suffering itself
[21]. Suffering is defined as individual and subjective pa-
tient’s perception, which contrasts with the fact that physi-
cians are the ones who diagnose it [22]. Previous studies
revealed that this seems even more challenging in case of
existential suffering [23, 24].
In clinical practice, medical decision-making for continu-
ous deep sedation is not only based on clinical indications
but also influenced by the social context, including pa-
tients’ and healthcare professionals’ intentions and views
[25]. According to clinical practice guidelines, continuous
deep sedation until death is only indicated with the inten-
tion to induce a state of decreased or absent awareness in
order to relieve a patient’s unbearable suffering and refrac-
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tory symptoms [12]. Previous findings reveal that compli-
ance with clinical practice guidelines seems better in the
case of palliative care expertise or when a consulting ex-
pert was called in [26]. Our findings revealed that pallia-
tive care clinicians have a more restrictive understanding
of palliative sedation and clearly exclude unintended se-
dation [27]. In contrast, outside specialised palliative care,
sedation was not always intended, but rather taken into ac-
count as a side effect of increased pain medication in ter-
minally ill patients. As a consequence, outside specialised
palliative care, opioids were sometimes used as sole agent
to induce sedation [28]. This indicates that some health-
care professionals might subsume the sedation practice un-
der possibly life-shortening end-of-life decisions, such as
intensified alleviation of pain and symptoms, instead of
viewed as a separate practice. In line with these findings
healthcare professionals less experienced in palliative care
tend to have ambiguous attitudes towards continuous deep
sedation and are more likely consider it as possibly life
shortening [29–31]. Current evidence does not suggest that
practicing continuous deep sedation until death is general-
ly emotionally burdensome. But the more healthcare pro-
fessionals struggle with justifying the sedation practice, the
higher their risk of experiencing emotional distress [24].
Our findings revealed that this appeared to be in part a
function of proper decision-making to reach a consensus
within the team, as well as with patients and family (e.g.,
lack of time in emergency case)
The variation in sedation understanding and practice is
furthermore related to setting-specific structural and per-
sonnel resources. Results from Belgium revealed that the
considerable variation in administration and monitoring
between family practitioners and medical specialists was
most likely affected by the different resources provided by
the respective clinical care setting [32]. Most of the in-
terviewed palliative care specialists worked in palliative
care units and thus reported frequent multidisciplinary ex-
change with experts of other hospital departments, con-
stant patient monitoring and continuous administration of
benzodiazepines through intravenous infusion. In primary
care and internal medicine, professionals often reported
limited options for multidisciplinary exchange, and diffi-
culty in ensuring overnight monitoring, intravenous infu-
sions and access to sedative medication. This lack of re-
sources might partly account for the variation observed
[28].
Our study indicates that medical decision-making for con-
tinuous deep sedation goes beyond a conceptual definition
or clinical indications. For future studies, the question re-
mains to what extent a definition can be reduced to ob-
jective parts without losing the purpose of providing in-
formation on good clinical practice. Therefore, the best
conceptual definition might not reflect the best clinical
practice in its fullest.
Implication for policy and practice
Adherence to guidelines on continuous deep sedation out-
side specialised palliative care remains modest. This might
be caused by a lack of shared knowledge or because the
implementation of current practice guidelines is not feasi-
ble. Knowledge transfer could be improved by increased
multidisciplinary networking, the preferred approach for
patient-centred care, and timely involvement of palliative
care consultants in order to encourage the early recognition
of palliative care needs. This might facilitate the coordina-
tion of care at a patient’s end of life and thus enable a mu-
tually developed consensus for defining and understanding
the distinct sedation practices. For long-term care facilities,
the presence of a physician experienced in geriatric pallia-
tive care working closely together with the nursing team
is crucial. Therefore, training and earlier involvement of
expert consultation teams in general internal medicine and
nursing homes is of high importance. Also, mobile pallia-
tive care consultant teams seem promising as they are not
only supportive for primary care physicians in long-term
care and home care, but also aim to reduce the number
of emergency hospitalisations. But despite an increasing
need, there is only a limited number of mobile palliative
care teams, and reimbursement is often not sufficient, at
least in Switzerland. Therefore, policy makers should fo-
cus on providing financial and regulatory support for the
implementation of palliative care services to provide re-
sources required for appropriate palliative sedation across
all care settings.
Limitations
Our results do not allow any conclusions about family
practitioners’ experience since we were unable to recruit
respondents. Possible reasons for the absence of family
practitioners might be lack of sedation experience, time
constraints or not recognising our study invitation in the
newsletter. For anonymity reasons, we were not able to re-
cruit family practitioners personally and therefore had to
reach them via the newsletter of the Swiss association of
general practitioners. Future studies are needed to investi-
gate family practitioners’ experience with the administra-
tion of sedative substances to keep a patient in deep seda-
tion until death. Another limitation is potential recall bias
since some healthcare professionals’ involvement in seda-
tion practice varied considerably and sometimes occurred
up to three years before this study.
Conclusions
We found that the understanding of “continuous deep se-
dation until death” varied considerably between healthcare
settings and palliative care specialisation. In order to move
forward, early involvement of palliative care experts, se-
dation training, as well as financial and regulatory support
should be provided to encourage multidisciplinary collabo-
ration and a common sedation understanding between pal-
liative care experts and physicians and nurses who practice
continuous deep sedation until death also outside spe-
cialised palliative care.
Acknowledgements
We thank all the physicians and nurses who participated in the study.
Financial disclosure
The author) disclosed receipt of the following financial support for the
research, authorship, and/or publication of this article: This work was
supported by the Swiss National Science Foundation (research grant
406740-139309, National Research Program 67 “End of Life”).
Potential competing interests
The authors declared no potential conflicts of interest with respect to
the research, authorship and/or publication of this article.
Original article Swiss Med Wkly. 2018;148:w14657
Swiss Medical Weekly · PDF of the online version · www.smw.ch
Published under the copyright license “Attribution – Non-Commercial – No Derivatives 4.0”.
No commercial reuse without permission. See http://emh.ch/en/services/permissions.html.
Page 7 of 8
References
1 Swart SJ, van der Heide A, van Zuylen L, Perez RSGM, Zuurmond
WWA, van der Maas PJ, et al. Considerations of physicians about the
depth of palliative sedation at the end of life. CMAJ.
2012;184(7):E360–6. doi: http://dx.doi.org/10.1503/cmaj.110847.
PubMed.
2 Miccinesi G, Rietjens JAC, Deliens L, Paci E, Bosshard G, Nilstun T, et
al.; EURELD Consortium. Continuous deep sedation: physicians’ expe-
riences in six European countries. J Pain Symptom Manage.
2006;31(2):122–9. doi: http://dx.doi.org/10.1016/j.jpainsym-
man.2005.07.004. PubMed.
3 Putman MS, Yoon JD, Rasinski KA, Curlin FA. Intentional sedation to
unconsciousness at the end of life: findings from a national physician
survey. J Pain Symptom Manage. 2013;46(3):326–34. doi:
http://dx.doi.org/10.1016/j.jpainsymman.2012.09.007. PubMed.
4 Seale C. Continuous deep sedation in medical practice: a descriptive
study. J Pain Symptom Manage. 2010;39(1):44–53. doi:
http://dx.doi.org/10.1016/j.jpainsymman.2009.06.007. PubMed.
5 Robijn L, Cohen J, Rietjens J, Deliens L, Chambaere K. Trends in Con-
tinuous Deep Sedation until Death between 2007 and 2013: A Repeated
Nationwide Survey. PLoS One. 2016;11(6):e0158188. doi:
http://dx.doi.org/10.1371/journal.pone.0158188. PubMed.
6 Chao YS, Boivin A, Marcoux I, Garnon G, Mays N, Lehoux P, et al.;
Advisory Committee; Canadian Medical Association; College of Family
Physicians of Canada; Canadian Bar Association; Ministère de la santé
et des services sociaux du Québec; Réseau des soins palliatifs du
Québec; Commissaire à la santé et au bien-être du Québec. International
changes in end-of-life practices over time: a systematic review. BMC
Health Serv Res. 2016;16(1):539. doi: http://dx.doi.org/10.1186/
s12913-016-1749-z. PubMed.
7 Bosshard G, Zellweger U, Bopp M, Schmid M, Hurst SA, Puhan MA, et
al. Medical end-of-Life practices in Switzerland: A comparison of 2001
and 2013. JAMA Intern Med. 2016;176(4):555–6. doi: http://dx.doi.org/
10.1001/jamainternmed.2015.7676. PubMed.
8 van der Heide A, van Delden JJM, Onwuteaka-Philipsen BD. End-of-
Life Decisions in the Netherlands over 25 Years. N Engl J Med.
2017;377(5):492–4. doi: http://dx.doi.org/10.1056/NEJMc1705630.
PubMed.
9 Hurst SA, Zellweger U, Bosshard G, Bopp M; Swiss Medical End-of-
Life Decisions Study Group. Medical end-of-life practices in Swiss cul-
tural regions: a death certificate study. BMC Med. 2018;16(1):54. doi:
http://dx.doi.org/10.1186/s12916-018-1043-5. PubMed.
10 Papavasiliou ES, Brearley SG, Seymour JE, Brown J, Payne SA. Pa-
pavasiliou ES, Brearley SG, Seymour JE, Brown J, Payne SA, on behalf
of EUROIMPACT. From sedation to continuous sedation until death:
how has the conceptual basis of sedation in end-of-life care changed
over time? J Pain Symptom Manage 2013; 5:706-723. J Pain Symptom
Manage. 2014;47(2):370. doi: http://dx.doi.org/10.1016/j.jpainsym-
man.2013.12.227. PubMed.
11 Abarshi E, Rietjens J, Robijn L, Caraceni A, Payne S, Deliens L, et al.;
EURO IMPACT. International variations in clinical practice guidelines
for palliative sedation: a systematic review. BMJ Support Palliat Care.
2017;7(3):223–9. PubMed.
12 Cherny NI, Radbruch L; Board of the European Association for Pallia-
tive Care. European Association for Palliative Care (EAPC) recom-
mended framework for the use of sedation in palliative care. Palliat
Med. 2009;23(7):581–93. doi: http://dx.doi.org/10.1177/
0269216309107024. PubMed.
13 Schildmann EK, Schildmann J, Kiesewetter I. Medication and monitor-
ing in palliative sedation therapy: a systematic review and quality as-
sessment of published guidelines. J Pain Symptom Manage.
2015;49(4):734–46. doi: http://dx.doi.org/10.1016/j.jpainsym-
man.2014.08.013. PubMed.
14 Hedinger D, Braun J, Zellweger U, Kaplan V, Bopp M; Swiss National
Cohort Study Group. Moving to and dying in a nursing home depends
not only on health - an analysis of socio-demographic determinants of
place of death in Switzerland. PLoS One. 2014;9(11):e113236. doi:
http://dx.doi.org/10.1371/journal.pone.0113236. PubMed.
15 Rietjens J, van Delden J, Onwuteaka-Philipsen B, Buiting H, van der
Maas P, van der Heide A. Continuous deep sedation for patients nearing
death in the Netherlands: descriptive study. BMJ.
2008;336(7648):810–3. doi: http://dx.doi.org/10.1136/
bmj.39504.531505.25. PubMed.
16 McCormack R, Clifford M, Conroy M. Attitudes of UK doctors towards
euthanasia and physician-assisted suicide: a systematic literature review
[Erratum]. Palliat Med. 2012;26(1):23–33. doi: http://dx.doi.org/
10.1177/0269216310397688. PubMed.
17 Foley R-A, Johnston WS, Bernard M, Canevascini M, Currat T, Borasio
GD, et al. Attitudes Regarding Palliative Sedation and Death Hastening
Among Swiss Physicians: A Contextually Sensitive Approach. Death
Stud. 2015;39(8):473–82. doi: http://dx.doi.org/10.1080/
07481187.2015.1029142. PubMed.
18 Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualita-
tive research (COREQ): a 32-item checklist for interviews and focus
groups. Int J Qual Health Care. 2007;19(6):349–57. doi:
http://dx.doi.org/10.1093/intqhc/mzm042. PubMed.
19 Schildmann E, Schildmann J. Palliative sedation therapy: a systematic
literature review and critical appraisal of available guidance on indica-
tion and decision making. J Palliat Med. 2014;17(5):601–11. doi:
http://dx.doi.org/10.1089/jpm.2013.0511. PubMed.
20 Papavasiliou ES, Brearley SG, Seymour JE, Brown J, Payne SA; EURO
IMPACT. From sedation to continuous sedation until death: how has the
conceptual basis of sedation in end-of-life care changed over time? J
Pain Symptom Manage. 2013;46(5):691–706. doi: http://dx.doi.org/
10.1016/j.jpainsymman.2012.11.008. PubMed.
21 Bozzaro C. Der Leidensbegriff im medizinischen Kontext: Ein Proble-
maufriss am Beispiel der tiefen palliativen Sedierung am Lebensende
[The concept of suffering in medicine: an investigation using the exam-
ple of deep palliative sedation at the end of life]. Ethik Med.
2015;27(2):93–106. doi: http://dx.doi.org/10.1007/s00481-015-0339-7.
22 Müller-Busch HC, Radbruch L, Strasser F, Voltz R. Empfehlungen zur
palliativen Sedierung [Definitions and recommendations for palliative
sedation]. Dtsch Med Wochenschr. 2006;131(48):2733–6. Article in
German. PubMed.
23 Bakogiannis A, Papavasiliou EE. Language Barriers to Defining Con-
cepts in Medicine: The Case of Palliative Sedation. Am J Hosp Palliat
Care. 2016;33(9):909–10. doi: http://dx.doi.org/10.1177/
1049909115586186. PubMed.
24 Ziegler S, Merker H, Schmid M, Puhan MA. The impact of the inpatient
practice of continuous deep sedation until death on healthcare profes-
sionals’ emotional well-being: a systematic review. BMC Palliat Care.
2017;16(1):30. doi: http://dx.doi.org/10.1186/s12904-017-0205-0.
PubMed.
25 Robijn L, Chambaere K, Raus K, Rietjens J, Deliens L. Reasons for
continuous sedation until death in cancer patients: a qualitative interview
study. Eur J Cancer Care (Engl). 2017;26(1):e12405. doi:
http://dx.doi.org/10.1111/ecc.12405. PubMed.
26 Hasselaar JGJ, Reuzel RPB, Verhagen SCAHHVM, de Graeff A, Vis-
sers KC, Crul BJP. Improving prescription in palliative sedation: com-
pliance with dutch guidelines. Arch Intern Med. 2007;167(11):1166–71.
doi: http://dx.doi.org/10.1001/archinte.167.11.1166. PubMed.
27 Maiser S, Estrada-Stephen K, Sahr N, Gully J, Marks S. A Survey of
Hospice and Palliative Care Clinicians’ Experiences and Attitudes Re-
garding the Use of Palliative Sedation. J Palliat Med.
2017;20(9):915–21. doi: http://dx.doi.org/10.1089/jpm.2016.0464.
PubMed.
28 Papavasiliou EE, Chambaere K, Deliens L, Brearley S, Payne S, Riet-
jens J, et al.; on behalf of EURO IMPACT. Physician-reported practices
on continuous deep sedation until death: A descriptive and comparative
study. Palliat Med. 2014;28(6):491–500. doi: http://dx.doi.org/10.1177/
0269216314530768. PubMed.
29 Foley R-A, Johnston WS, Bernard M, Canevascini M, Currat T, Borasio
GD, et al. Attitudes Regarding Palliative Sedation and Death Hastening
Among Swiss Physicians: A Contextually Sensitive Approach. Death
Stud. 2015;39(8):473–82. doi: http://dx.doi.org/10.1080/
07481187.2015.1029142. PubMed.
30 Inghelbrecht E, Bilsen J, Mortier F, Deliens L. Nurses’ attitudes towards
end-of-life decisions in medical practice: a nationwide study in Flanders,
Belgium. Palliat Med. 2009;23(7):649–58. doi: http://dx.doi.org/
10.1177/0269216309106810. PubMed.
31 Inghelbrecht E, Bilsen J, Mortier F, Deliens L. Continuous deep seda-
tion until death in Belgium: a survey among nurses. J Pain Symptom
Manage. 2011;41(5):870–9. doi: http://dx.doi.org/10.1016/j.jpainsym-
man.2010.07.022. PubMed.
32 Putman MS, Yoon JD, Rasinski KA, Curlin FA. Intentional sedation to
unconsciousness at the end of life: findings from a national physician
survey. J Pain Symptom Manage. 2013;46(3):326–34. doi:
http://dx.doi.org/10.1016/j.jpainsymman.2012.09.007. PubMed.
Original article Swiss Med Wkly. 2018;148:w14657
Swiss Medical Weekly · PDF of the online version · www.smw.ch
Published under the copyright license “Attribution – Non-Commercial – No Derivatives 4.0”.
No commercial reuse without permission. See http://emh.ch/en/services/permissions.html.
Page 8 of 8
